Cargando…
CD8(+), HLA-unrestricted, cytotoxic T-lymphocyte line against malignant melanoma
A CD8(+ )cytotoxic T lymphocyte (CTL) line was derived from the peripheral blood mononuclear cells of a patient with primary melanoma. The CD8(+ )CTL line specifically lysed the autologous primary melanoma cells and not the natural killer cell-sensitive K562 cells or lymphokine activated killer cell...
Autores principales: | Somasundaram, Rajasekharan, Caputo, Laura, Guerry, DuPont, Herlyn, Dorothee |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1308870/ https://www.ncbi.nlm.nih.gov/pubmed/16281981 http://dx.doi.org/10.1186/1479-5876-3-41 |
Ejemplares similares
-
In vitro migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2
por: Berencsi, Klara, et al.
Publicado: (2011) -
Pre-clinical modeling of cutaneous melanoma
por: Rebecca, Vito W., et al.
Publicado: (2020) -
Immunotargeting of tumor subpopulations in melanoma patients: A paradigm shift in therapy approaches
por: Maurer, Margarita, et al.
Publicado: (2012) -
Antimelanoma CTL recognizes peptides derived from an ORF transcribed from the antisense strand of the 3′ untranslated region of TRIT1
por: Swoboda, Rolf K, et al.
Publicado: (2015) -
PBRM1 and the glycosylphosphatidylinositol biosynthetic pathway promote tumor killing mediated by MHC-unrestricted cytotoxic lymphocytes
por: Menasche, Bridget L., et al.
Publicado: (2020)